What is Veracyte Inc (VCYT)?
Veracyte Inc is a genomic diagnostics company focused on improving diagnostic accuracy and patient care through advanced molecular testing. The company develops and commercializes diagnostic tests that aid in the evaluation of thyroid, lung, and other cancers, as well as idiopathic pulmonary fibrosis. Its products utilize genomic technology to provide physicians with more precise information, which can help guide treatment decisions and reduce unnecessary surgeries. Veracyte's approach integrates genomic data with clinical and pathological information to enhance diagnostic confidence. The company operates in the healthcare sector, serving hospitals, pathology groups, and medical practices. Its offerings are designed to address diagnostic challenges by providing non-invasive or minimally invasive testing options. Veracyte's work contributes to the broader field of precision medicine by enabling tailored treatment strategies based on molecular insights. The company is headquartered in South San Francisco, California, and engages in research collaborations and partnerships to expand its diagnostic capabilities.
Veracyte Inc Stock Price Today: Live Overview
The price today is shaped by trading fluctuations in Veracyte Inc, currently trading at $32.91. The price has varied between $32.27 and $33.56 during the day, with a daily change percentage of +2.216%.
FAQ: Veracyte Inc (VCYT)
What is the current price of VCYT stock?
The current price is $32.91.
Does VCYT pay dividends?
Veracyte Inc does not currently pay dividends.
Does VCYT have a formal corporate presence or regional headquarters in the UAE?
Veracyte Inc has no official office or subsidiary in the UAE and operates through partners only.
What is VCYT best known for?
Veracyte Inc is most famous for its genomic diagnostic tests in thyroid and lung diseases.
What assets are typically shown together with VCYT?
Commonly shown alongside VCYT: Curis, Inc., Ginkgo Bioworks Holdings Inc., Pluri Inc.
Latest shares articles



